At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Mar 16, 2026 at 20:00 ET
Multiple executives at Esperion Therapeutics, including the CEO, CFO, and Chief Legal Officer, sold shares in the open market totaling approximately $102,352 over the past week. These sales coincided with large non-cash stock award grants to the same insiders, a routine compensation event, suggesting the sales may be part of pre-arranged 10b5-1 plans or personal liquidity management rather than a signal of fundamental concerns.
- CEO Sheldon Koenig sold $69,547 worth of shares, representing the largest individual sale in the cluster.
- CFO Benjamin Halladay and Chief Legal Officer Benjamin Looker sold $17,377 and $15,429 worth of shares, respectively.
- All three executives received substantial non-cash stock awards on March 13, totaling over 1.8 million shares collectively, which is consistent with annual equity compensation practices.
- Total open-market sales in the cluster amount to $102,352, representing just 0.015% of the company's $696M market cap, well below the 0.1% threshold for materiality.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access